Skip Navigation


NDT Advance Access originally published online on November 29, 2007
Nephrology Dialysis Transplantation 2008 23(4):1135-1143; doi:10.1093/ndt/gfm808
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
23/4/1135    most recent
gfm808v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Rosenberger, C.
Right arrow Articles by Heyman, S. N.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosenberger, C.
Right arrow Articles by Heyman, S. N.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2007]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.For Permissions, please e-mail: journals.permissions@oxfordjournals.org



Evidence for sustained renal hypoxia and transient hypoxia adaptation in experimental rhabdomyolysis-induced acute kidney injury

Christian Rosenberger1, Marina Goldfarb2, Ahuva Shina3, Sebastian Bachmann4, Ulrich Frei1, Kai-Uwe Eckardt5, Thomas Schrader6, Seymour Rosen7 and Samuel N. Heyman3

1 Department of Nephrology and Medical Intensive Care, Charité Universitaetsmedizin, Berlin, Germany 2 Nephrology Unit, Bikur Holim Hospital 3 Hadassah University Hospital Mt. Scopus and the Hebrew Medical School, Jerusalem, Israel 4 Department of Anatomy, Humboldt University, Berlin 5 Department of Nephrology and Hypertension, University of Erlangen-Nuremberg, Erlangen, Germany 6 Department of Pathology, Charité Universitätsmedizin, Berlin, Germany 7 Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA

Christian Rosenberger, Nephrology and Medical Intensive Care, Charité Universitaetsmedizin, Augustenburger Platz 1, 13353 Berlin, Germany. Tel: +49-30-450553232; Fax: +49-30-79741921; E-mail: chrosenbe{at}aol.com



  Abstract

Background. Indirect evidence suggests that hypoxia contributes to the pathophysiology of rhabdomyolysis-induced acute kidney injury (AKI). However, the cellular location and kinetics of hypoxia, as well as potential hypoxia adaptation are unclear.

Methods. Rhabdomyolysis was induced in rats by IM glycerol (GLY) injection, which largely recapitulates the full clinical syndrome. Additional rats received IV myoglobin (MYO), in order to assess the contribution of MYO per se. We performed immunohistochemistry for hypoxia markers [pimonidazole (PIM) adducts and hypoxia-inducible factors (HIFs)] and the cell-protective HIF target gene heme oxygenase-1 (HO-1). Furthermore, we sought a potential negative feedback loop to terminate HIF activation, driven by HIF prolyl-hydroxylase-2 (PHD-2).

Results. In GLY, progressive tubular injury, mainly of proximal tubules (PT), developed over time, but its extent was heterogeneous. PIM, HIF{alpha} and HO-1 were all absent in controls, but strongly positive in GLY, with a specific spatio-temporal pattern. In PT, (a) PIM was detectable throughout the study with a maximum at 6 h, (b) HIF was activated only at 3 h and (c) HO-1 and PHD-2 appeared at 6 h and persisted at a lower level at 24 h. Apart from tubular cast formation, MYO did not cause overt tissue damage, but led to strong activation of HIFs, in a pattern similar to 3 h of GLY.

Conclusions. Our data suggest that renal hypoxia occurs in rhabdomyolysis, and that MYO, at least partly, contributes to hypoxia generation. Since in the most affected tubules transcriptional hypoxia adaptation is transient and inhomogeneous, pharmacologic HIF enhancement holds the potential to improve outcome in rhabdomyolysis-induced AKI.

Keywords: acute renal failure; heme oxygenase-1; HIF prolyl hydroxylase-2; hypoxia-inducible factors; pimonidazole

Received for publication: 21. 8.07
Accepted in revised form: 16.10.07


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.